STOCK TITAN

SCWORX CORP 8-K Filings

WORX OTC

Every 8-K that SCWORX CORP (WORX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow WORX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full WORX filings page.

Rhea-AI Summary

SCWorx Corp. (WORX) reports that Nasdaq has notified the company it no longer meets Nasdaq Listing Rule 5550(a)(4), which requires at least 500,000 publicly held shares for continued listing on The Nasdaq Capital Market. As of the company’s September 1, 2026 confirmation to Nasdaq, it had 89,782 publicly held shares, creating an additional basis for delisting.

The notice follows a previously completed 1‑for‑12 reverse stock split, effective August 3, 2026, which helped the stock close at or above $1.00 for twenty consecutive trading days but reduced the number of publicly held shares. Because the reverse split caused non‑compliance with the publicly held share standard, Nasdaq rules treat SCWorx as still non‑compliant with the minimum bid price requirement until it first regains compliance with the publicly held share and market value of publicly held shares tests and then maintains a closing bid price of at least $1.00 for the required period.

The company also remains below the $1,000,000 market value of publicly held shares requirement, for which Nasdaq has provided a compliance period expiring January 20, 2027. SCWorx is evaluating alternatives, including issuing additional common shares, which it states would be dilutive and could pressure the share price, and it plans to submit written views to the Nasdaq Hearings Panel by September 9, 2026. The company cautions there is no assurance it will regain compliance or avoid delisting.

Rhea-AI Summary

SCWorx Corp. approved a 1-for-12 reverse stock split of its common stock, effective at 11:59 p.m. Eastern Time on August 3, 2026. Every twelve shares outstanding will be combined into one share, reducing issued and outstanding shares from 1,066,918 to approximately 89,000.

The number of authorized shares is unchanged, which will significantly increase authorized but unissued shares and could result in substantial dilution if issued. The split is being implemented to help regain compliance with Nasdaq's $1.00 minimum bid price rule by August 28, 2026, but may reduce liquidity, increase volatility and does not guarantee continued Nasdaq listing.

Rhea-AI Summary

SCWorx Corp. details its efforts to maintain its listing on The Nasdaq Capital Market after previously falling below Nasdaq’s $1.00 per share minimum bid price requirement and receiving a delisting determination.

Following an appeal and a June 17, 2026 Nasdaq Hearings Panel decision granting continued listing subject to conditions, SCWorx received a partial compliance letter on July 24, 2026 confirming it satisfied the first provision of its compliance plan. The company must still comply with all remaining Nasdaq Listing Rules, including maintaining the minimum bid price for 20 consecutive trading days, and states there can be no assurance it will ultimately regain full compliance.

Rhea-AI Summary

SCWorx Corp. received a Nasdaq notice dated July 24, 2026 stating that its Market Value of Publicly Held Shares (MVPHS) did not meet the required minimum of $1,000,000 for 30 consecutive business days, from June 10, 2026 through July 23, 2026, under Nasdaq Listing Rule 5550(a)(5).

This triggers a 180‑day compliance period through January 20, 2027. If at any time in that period SCWorx’s MVPHS is at least $1,000,000 for a minimum of ten consecutive business days (or a longer period Nasdaq may require, up to twenty days), Nasdaq will confirm compliance. The company is reviewing alternatives to regain and sustain compliance; as of the date of the report, the board had not chosen a specific course of action. Failure to regain compliance would subject the common stock to delisting, though SCWorx could appeal, with no assurance of success.

Rhea-AI Summary

SCWorx Corp. held its 2026 Annual Meeting of Stockholders on July 22, 2026. Stockholders elected directors Timothy A. Hannibal, Troy Kirchenbauer, Vincent Matozzo and Michael Burke to serve until the next annual meeting and until their successors are elected and qualified.

In a non-binding advisory vote on executive compensation, stockholders cast 112,820 votes for, 128,981 against and 1,394 abstentions, so the compensation of named executive officers was not approved. Stockholders ratified Astra Audit & Advisory, LLC as independent auditors for the year ended December 31, 2026, with 446,290 votes for and 24,963 against.

Stockholders also approved an amendment to the certificate of incorporation to authorize a reverse stock split of common stock, at a ratio within the range of 1/1.5 and 1/20, at the board’s discretion, if needed to regain compliance with Nasdaq Rule 5550(a)(2) requiring a minimum $1.00 bid price.

Rhea-AI Summary

SCWorx Corp. received a decision from a Nasdaq Hearings Panel allowing its common stock to continue listing on Nasdaq, subject to strict compliance conditions. Trading had been suspended after the stock failed to meet the Nasdaq minimum bid price of $1.00 per share.

To regain trading on Nasdaq, SCWorx must obtain shareholder approval for a reverse stock split by July 22, 2026, implement the reverse split by August 3, 2026, and then demonstrate a closing bid of at least $1.00 per share for 20 consecutive trading days by August 28, 2026. If it fails, the stock would remain quoted on OTC Markets, where it has approval for quotation on the OTCQB Market.

Rhea-AI Summary

SCWorx Corp. received notice from Nasdaq on April 7, 2026 that its common stock will be delisted from the Nasdaq Capital Market for failing to meet the minimum bid price requirement of $1.00 per share under Nasdaq Rule 5550(a)(2) by the April 6, 2026 deadline.

Nasdaq plans to suspend trading on April 14, 2026 and file a Form 25-NSE to remove the stock from listing and registration, though SCWorx has appealed this determination to a Nasdaq hearings panel. To address the deficiency, the company amended its certificate of incorporation to implement a 1-for-15 reverse stock split, combining every 15 outstanding shares into one share, effective at the open of trading on April 10, 2026.

To regain compliance, the post-split common stock must trade at or above $1.00 per share for ten consecutive trading days. The company states it expects to regain compliance as a result of the reverse split but cautions there is no assurance it will succeed or prevail in its appeal, and that failure to remain listed on Nasdaq could adversely affect the company.

Rhea-AI Summary

SCWorx Corp. has approved a 1-for-15 reverse stock split of its common stock by amending its certificate of incorporation. Every 15 shares of outstanding common stock will be combined into one share. The reverse split is expected to be effective at the start of trading on April 10, 2026.

The company is undertaking this reverse split to help regain compliance with the Nasdaq Stock Market’s minimum bid price rule, which requires its common stock to trade at or above $1.00 per share for ten consecutive trading days. SCWorx notes there is no assurance this step will restore compliance, and if compliance is not regained, its common stock will be delisted from Nasdaq.

Rhea-AI Summary

SCWorx Corp. (WORX) received a 180-day Nasdaq extension to regain bid-price compliance and now has until April 6, 2026 to meet the $1.00 minimum under Nasdaq Rules 5550(a)(2) and 5810(c)(3)(A). The company will be deemed compliant if its common stock closes at $1.00 or more for at least 10 consecutive business days before that date.

SCWorx states it is monitoring its share price and, if compliance is not regained within the extension, it plans to implement a reverse stock split previously approved by shareholders. If compliance is still not achieved, Nasdaq may issue a delisting notice, which the company could appeal to a hearings panel. The extension has no immediate effect on trading; shares continue on the Nasdaq Capital Market under the symbol WORX.

Rhea-AI Summary

SCWorx Corp. entered into warrant inducement agreements that led holders to exercise 2,064,000 existing warrants at an exercise price of $0.3496 per share, generating approximately $721,574 in gross proceeds. In return, the company agreed to issue new unregistered warrants to purchase 4,128,000 shares of common stock at an exercise price of $0.31004 per share, which will be exercisable for five years after required stockholder approvals, including an increase in authorized common stock. The agreements limit additional equity sales until ninety days after the stockholder approval date, include a 4.99% beneficial ownership cap on warrant exercises, and require SCWorx to file and maintain a resale registration statement for the new warrant shares, with liquidated damages if it fails to meet these registration obligations. The securities were issued under a Regulation D exemption, and the resale of shares issued from the existing warrants is already registered.